about
Biology of adeno-associated viral vectors in the central nervous systemPrion switching in response to environmental stressAtaxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALSComparison of an expanded ataxia interactome with patient medical records reveals a relationship between macular degeneration and ataxiaStructural basis for recognition of the third SH3 domain of full-length R85 (R85FL)/ponsin by ataxin-7SCAMP5 links endoplasmic reticulum stress to the accumulation of expanded polyglutamine protein aggregates via endocytosis inhibitionThe DNAJB6 and DNAJB8 protein chaperones prevent intracellular aggregation of polyglutamine peptidesObserving Huntington's Disease: the European Huntington's Disease Network's REGISTRYAltered ribostasis: RNA-protein granules in degenerative disordersProRepeat: an integrated repository for studying amino acid tandem repeats in proteinsIntracellular degradation of misfolded proteins in polyglutamine neurodegenerative diseasesmiR-19, miR-101 and miR-130 co-regulate ATXN1 levels to potentially modulate SCA1 pathogenesisComparative genomics and molecular dynamics of DNA repeats in eukaryotesAnimal models of polyglutamine diseases and therapeutic approachesPathogenic mechanisms of a polyglutamine-mediated neurodegenerative disease, spinocerebellar ataxia type 1Unstable nucleotide repeat minireview series: a molecular biography of unstable repeat disordersZinc-finger directed double-strand breaks within CAG repeat tracts promote repeat instability in human cellsPrion-like domains as epigenetic regulators, scaffolds for subcellular organization, and drivers of neurodegenerative diseaseAn Overview of Genome Organization and How We Got There: from FISH to Hi-CRAN translation and frameshifting as translational challenges at simple repeats of human neurodegenerative disordersCell biology of spinocerebellar ataxiaStructural studies of CNG repeatsMouse models of polyglutamine diseases: review and data table. Part ITargeting Hsp90/Hsp70-based protein quality control for treatment of adult onset neurodegenerative diseasesMechanisms of RNA-induced toxicity in CAG repeat disordersDNA triplet repeat expansion and mismatch repairThe balancing act of DNA repeat expansionsMouse models of polyglutamine diseases in therapeutic approaches: review and data table. Part II.Beyond the glutamine expansion: influence of posttranslational modifications of ataxin-1 in the pathogenesis of spinocerebellar ataxia type 1Genetics of Parkinson's disease - a clinical perspectiveTherapeutic Approaches for Inhibition of Protein Aggregation in Huntington's DiseaseThe unstable repeats--three evolving faces of neurological diseasePolyglutamine neurodegeneration: expanded glutamines enhance native functionsThe hidden side of unstable DNA repeats: Mutagenesis at a distanceCurrent understanding of the role of microRNAs in spinocerebellar ataxiasA Drosophila model of ALS: human ALS-associated mutation in VAP33A suggests a dominant negative mechanismThe N17 domain mitigates nuclear toxicity in a novel zebrafish Huntington's disease model.N17 Modifies mutant Huntingtin nuclear pathogenesis and severity of disease in HD BAC transgenic micedAtaxin-2 mediates expanded Ataxin-1-induced neurodegeneration in a Drosophila model of SCA1Large Polyglutamine Repeats Cause Muscle Degeneration in SCA17 Mice.
P2860
Q21129328-81ECF647-C7B1-4AF1-9937-259BF2097D4DQ21145845-0523F7C7-ACEB-486A-A61C-1E23E616FDB6Q24297462-E2CB8EA6-9EEB-44CA-8C40-B85E96C05C12Q24307380-3ED77B4A-93E2-44D9-8721-442800AEDE58Q24312785-79C7BB9A-7658-4A31-847A-7C37A78EC7C7Q24314585-2248667E-21FE-442B-B7B2-4D835F321D9DQ24338933-7BDD75A6-7900-4EF4-ACBC-F50FD9DACC7CQ24598264-BB631C78-E93D-475A-B14F-467EF13E59A6Q24604643-A5E45A00-FE49-4FC6-BA08-7C25A7AAA856Q24622828-B4E0B17E-A7CE-4323-9D32-0396A52D3C25Q24644954-81EC5907-31CF-4C4F-ACA5-91BDCB2F96F3Q24647507-52BFCF78-627E-4F40-BA04-5A4F2A90E093Q24650948-98C776B5-61F8-40BD-9A8A-904BF375409AQ24655528-95593D09-302C-4ED9-A73F-588803F5116CQ24655547-432DB922-653A-416A-945A-2DB14C235A49Q24655565-7C3FF9ED-9E9B-40B0-8644-8B8D9156F5C9Q24658337-D94C4B0C-EADE-4227-B76B-3E83DC11B8E2Q26753190-DF1E4B7E-CC00-45CD-89FE-A7D99ACB910FQ26801741-8E30AC25-3D37-4BE8-A18D-8E76A59C1E5CQ26823908-58F70A41-E0BF-444B-9C11-89FD12FE0FBFQ26829511-EF3DE1EB-EA49-4E1F-82BE-268472F1E760Q26851232-C4E9C82B-7992-472D-AE55-A1CFAC1A7DCAQ26853025-E705EFA3-22E5-44E0-8D80-2BFEEB5AF2EFQ26859909-AE14B596-D6CB-47E9-9E22-7BC839FB50A0Q26860030-3110ACE6-5B13-48C7-BC05-2F05A335D2AEQ26996542-FC6DB190-4B65-4D88-B4DA-E5562629D39BQ27001959-84101EF3-6CBC-451F-9DB9-BFAA097AA905Q27005950-AF20B1F5-9290-421F-85FF-8416110964DDQ27008548-9492991F-2BF3-4056-A93B-3B0D088062C1Q27022109-E5DA7913-1595-49C1-BA91-361B3DEBD51DQ27022757-EB403A78-2152-42E1-84ED-75550A9D8C7EQ27025923-72DB0188-9DC3-4816-A868-EBB6B01C3B14Q27026773-F1BD597B-AAB6-47D2-8C7C-6815FD99C054Q27027501-FEF1869C-C937-4BA6-907B-F807944F3633Q27028008-743E4D5F-B307-47E7-8DD1-A27CEAC7FFABQ27301268-A99062B0-AF8B-4774-8E10-1F3AA94E2536Q27301298-65D86CA6-C080-4666-BB88-BDB5DB214BA3Q27306025-62198713-BFC6-4086-8D8A-BEA7DB59A98FQ27314605-52373369-7555-4EEE-8482-B605A5EFCCE0Q27320163-416D7451-AFAE-4876-9178-E16DB000155E
P2860
description
2007 nî lūn-bûn
@nan
2007 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Trinucleotide Repeat Disorders
@ast
Trinucleotide Repeat Disorders
@en
type
label
Trinucleotide Repeat Disorders
@ast
Trinucleotide Repeat Disorders
@en
prefLabel
Trinucleotide Repeat Disorders
@ast
Trinucleotide Repeat Disorders
@en
P3181
P1476
Trinucleotide repeat disorders
@en
P2093
Harry T. Orr
P304
P3181
P356
10.1146/ANNUREV.NEURO.29.051605.113042
P577
2007-01-01T00:00:00Z